Mitchell P. Kopin 13D and 13G filings for Lixte Biotechnology Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 06:19 am Purchase | 2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Mitchell P. Kopin | 138,763 4.990% | 138,763 (New Position) | Filing |